New endoscope to target colon tumours

May 10, 2017

European scientists are working on the development of an innovative, compact and easy-to-use endoscopic device for identifying and diagnosing preprecancerous polyps and early colon cancers. Worldwide, colon cancer remains the third most common cancer in men, behind lung and prostate cancer, and second in women, behind breast cancer.

Colorectal ranks as one of the world's most predominant cancers, affecting approximately one in ten people during their life and causing almost 700,000 annual deaths globally. Almost 95 percent of these cases are adenocarcinomas, which typically start as a growth of tissue called a polyp.

Today, the main method to achieve early detection of the disease is colonoscopy. While up to 40 percent of the patients under routine analysis colonoscopy present one or more , almost 30 percent of these polyps are not detected, especially in the case of flat polyps. Of those detected, 29 to 42 percent are generally hyperplastic, and will not develop into cancer. The remainder are neoplastic polyps, which are of primary importance because they harbor malignant potential and represent a stage in the development of . For this reason, it is essential to identify these polyps at an early stage.

Speaking about the PICCOLO Project Dr. Artzai Picon (Tecnalia) said "We hope that PICCOLO will provide major benefits over traditional colonoscopy. Firstly, by developing an advanced endoscope, using both (OCT) and multi-photon tomography (MPT), we will provide high-resolution structural and functional imaging, giving details of the changes occurring at the cellular level comparable to those obtained using traditional histological techniques. Furthermore, when multiple polyps are detected in a patient, the current gold standard procedure is to remove all of them, followed by microscopic tissue analysis. Removal of hyperplastic polyps, which carry no malignant potential, and the subsequent costly histopathological analysis, might be avoided through the use of the PICCOLO endoscope probe, which could allow image-based diagnosis without the need for tissue biopsies."

The long-term potential for this project is exciting. Not only will it provide a new approach in colon cancer detection, but the new image-based diagnosis methods could be applied to diseases in other organs of the body. The PICCOLO team hope to refine their first prototype by the end of 2018 and begin clinical trials around 2020.

Explore further: Technology advances help to prevent, lessen impact of colon cancer

Related Stories

Technology advances help to prevent, lessen impact of colon cancer

March 14, 2017
Approximately 140,000 people are diagnosed with colorectal cancer in the U.S. each year. March is Colorectal Cancer Awareness Month.

Review: Colon capsule endoscopy accurate in polyp detection

November 1, 2016
(HealthDay)—Colon capsule endoscopy (CCE), especially second-generation CCE (CCE-2), has high sensitivity and specificity for detecting colorectal polyps, according to a review published in the November issue of Clinical ...

Certain types of polyps may warrant keeping closer tabs on the colon

April 13, 2016
Being on the lookout for certain features of polyps may help physicians keep a closer eye on patients at risk for colorectal cancer.

Post-polyp detection, CRC risk ID'd by colonoscopy factors

August 21, 2012
(HealthDay) -- In the community setting, after colonoscopic polyp detection, colonoscopy-related factors such as incomplete polyp removal and lack of surveillance colonoscopies are more important than polyp characteristics ...

Estimating the risk of bowel cancer

August 19, 2013
Polyps in the mucosa of the colon are a common finding during screening colonoscopies. Some sub-groups of polyps are classed as precursors of bowel cancer. Until now, it has not been possible to precisely estimate the risk ...

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.